Cargando…

Hepatitis B Virus Immunity Gap: A Six-Year Laboratory Data Review of Hepatitis B Serological Profiles in Gauteng Province, South Africa

BACKGROUND: In 1995, the hepatitis B vaccine in South Africa was incorporated into the childhood expanded programme of immunization. We report on immunity gaps of laboratory-based hepatitis B virus (HBV) among patients in public facilities in Gauteng Province from 1st January 2014 to 31st December 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Mbenenge, Nonhlanhla, Subramoney, Kathleen, Gascua Adu-Gyamfi, Clement, Treurnicht, Florette K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208757/
https://www.ncbi.nlm.nih.gov/pubmed/37234693
http://dx.doi.org/10.1155/2023/6374874
_version_ 1785046737009770496
author Mbenenge, Nonhlanhla
Subramoney, Kathleen
Gascua Adu-Gyamfi, Clement
Treurnicht, Florette K.
author_facet Mbenenge, Nonhlanhla
Subramoney, Kathleen
Gascua Adu-Gyamfi, Clement
Treurnicht, Florette K.
author_sort Mbenenge, Nonhlanhla
collection PubMed
description BACKGROUND: In 1995, the hepatitis B vaccine in South Africa was incorporated into the childhood expanded programme of immunization. We report on immunity gaps of laboratory-based hepatitis B virus (HBV) among patients in public facilities in Gauteng Province from 1st January 2014 to 31st December 2019. Methodology. We analyzed HBV serological data extracted from the National Health Laboratory Services Central Data Warehouse (NHLS CDW). A descriptive analysis was performed for hepatitis B surface antigen (HBsAg), antibodies to HBV core (anti-HBc) total, anti-HBc IgM, and antibodies to HBV surface antigen (anti-HBs) according to annual distribution, age groups, and sex. RESULTS: The HBsAg positivity rate was 7.0% (75,596/1,095,561; p=0.001): 7.4% (96,532/944,077) in the 25 years and over age group and 4.0% (358/9,268 and 325/10,864) in the under 5 and 13–24 year age groups. The positivity rates of the other HBV serological markers were as follows: anti-HBc total was 37.0% (34,377/93,711; p  <  0.001), anti-HBc IgM was 2.4% (5,661/239,237; p=0.05), and anti-HBs was 37.0% (76,302/206,138; p ≤ 0.001). Naturally acquired HBV immunity was detected in 25.7% (11,188/43,536) of patients in the 25 years and over age group, and 9.7% and 8.2% (113/1,158 and 541/6,522) among those under 5 years and 13–24 year age group, respectively (p  <  0.001). Vaccine-induced immunity was 56.6% (656/1,158) in children under 5 years and 10.2% (4,425/43,536) among those 25 years and above (p  <  0.001). Fifty-six percent (29,404/52,581) of patients were HBV seronegative; predominantly among patients in the 13–24 year age group (60.6%; (3,952/6,522)) and 25 years and over (56.3% (24,524/43,536)) (p=<0.001). CONCLUSION: The HBV infection seroprevalence remains high in South Africa, with Gauteng province having high intermediate endemicity. However, the HBV immunity gap has shifted from younger children to older children and adults.
format Online
Article
Text
id pubmed-10208757
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-102087572023-05-25 Hepatitis B Virus Immunity Gap: A Six-Year Laboratory Data Review of Hepatitis B Serological Profiles in Gauteng Province, South Africa Mbenenge, Nonhlanhla Subramoney, Kathleen Gascua Adu-Gyamfi, Clement Treurnicht, Florette K. Adv Virol Research Article BACKGROUND: In 1995, the hepatitis B vaccine in South Africa was incorporated into the childhood expanded programme of immunization. We report on immunity gaps of laboratory-based hepatitis B virus (HBV) among patients in public facilities in Gauteng Province from 1st January 2014 to 31st December 2019. Methodology. We analyzed HBV serological data extracted from the National Health Laboratory Services Central Data Warehouse (NHLS CDW). A descriptive analysis was performed for hepatitis B surface antigen (HBsAg), antibodies to HBV core (anti-HBc) total, anti-HBc IgM, and antibodies to HBV surface antigen (anti-HBs) according to annual distribution, age groups, and sex. RESULTS: The HBsAg positivity rate was 7.0% (75,596/1,095,561; p=0.001): 7.4% (96,532/944,077) in the 25 years and over age group and 4.0% (358/9,268 and 325/10,864) in the under 5 and 13–24 year age groups. The positivity rates of the other HBV serological markers were as follows: anti-HBc total was 37.0% (34,377/93,711; p  <  0.001), anti-HBc IgM was 2.4% (5,661/239,237; p=0.05), and anti-HBs was 37.0% (76,302/206,138; p ≤ 0.001). Naturally acquired HBV immunity was detected in 25.7% (11,188/43,536) of patients in the 25 years and over age group, and 9.7% and 8.2% (113/1,158 and 541/6,522) among those under 5 years and 13–24 year age group, respectively (p  <  0.001). Vaccine-induced immunity was 56.6% (656/1,158) in children under 5 years and 10.2% (4,425/43,536) among those 25 years and above (p  <  0.001). Fifty-six percent (29,404/52,581) of patients were HBV seronegative; predominantly among patients in the 13–24 year age group (60.6%; (3,952/6,522)) and 25 years and over (56.3% (24,524/43,536)) (p=<0.001). CONCLUSION: The HBV infection seroprevalence remains high in South Africa, with Gauteng province having high intermediate endemicity. However, the HBV immunity gap has shifted from younger children to older children and adults. Hindawi 2023-05-17 /pmc/articles/PMC10208757/ /pubmed/37234693 http://dx.doi.org/10.1155/2023/6374874 Text en Copyright © 2023 Nonhlanhla Mbenenge et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Mbenenge, Nonhlanhla
Subramoney, Kathleen
Gascua Adu-Gyamfi, Clement
Treurnicht, Florette K.
Hepatitis B Virus Immunity Gap: A Six-Year Laboratory Data Review of Hepatitis B Serological Profiles in Gauteng Province, South Africa
title Hepatitis B Virus Immunity Gap: A Six-Year Laboratory Data Review of Hepatitis B Serological Profiles in Gauteng Province, South Africa
title_full Hepatitis B Virus Immunity Gap: A Six-Year Laboratory Data Review of Hepatitis B Serological Profiles in Gauteng Province, South Africa
title_fullStr Hepatitis B Virus Immunity Gap: A Six-Year Laboratory Data Review of Hepatitis B Serological Profiles in Gauteng Province, South Africa
title_full_unstemmed Hepatitis B Virus Immunity Gap: A Six-Year Laboratory Data Review of Hepatitis B Serological Profiles in Gauteng Province, South Africa
title_short Hepatitis B Virus Immunity Gap: A Six-Year Laboratory Data Review of Hepatitis B Serological Profiles in Gauteng Province, South Africa
title_sort hepatitis b virus immunity gap: a six-year laboratory data review of hepatitis b serological profiles in gauteng province, south africa
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208757/
https://www.ncbi.nlm.nih.gov/pubmed/37234693
http://dx.doi.org/10.1155/2023/6374874
work_keys_str_mv AT mbenengenonhlanhla hepatitisbvirusimmunitygapasixyearlaboratorydatareviewofhepatitisbserologicalprofilesingautengprovincesouthafrica
AT subramoneykathleen hepatitisbvirusimmunitygapasixyearlaboratorydatareviewofhepatitisbserologicalprofilesingautengprovincesouthafrica
AT gascuaadugyamficlement hepatitisbvirusimmunitygapasixyearlaboratorydatareviewofhepatitisbserologicalprofilesingautengprovincesouthafrica
AT treurnichtflorettek hepatitisbvirusimmunitygapasixyearlaboratorydatareviewofhepatitisbserologicalprofilesingautengprovincesouthafrica